16 articles for HJ Jung
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.
Korea Research Institute of Chemical Technology
Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads.
Yonsei University
Design, synthesis, and anti-melanogenic efficacy of 2-mercaptobenzoxazoles with nanomolar tyrosinase activity inhibition.
Pusan National University
In vitro and in vivo anti-pigmentation effects of 2-mercaptobenzimidazoles as nanomolar tyrosinase inhibitors on mammalian cells and zebrafish embryos: Preparation of pigment-free zebrafish embryos.
Pusan National University
Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.
Korea Research Institute of Chemical Technology
Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.
Sungkyunkwan University
Identification of BR101549 as a lead candidate of non-TZD PPARĪ³ agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR.
Boryung Pharmaceuticals
Discovery of the bifunctional modulator of angiotensin II type 1 receptor (AT1R) and PPARĪ³ derived from the AT1R antagonist, Fimasartan.
Boryung Pharmaceuticals
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
Hebrew University of Jerusalem
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
Cayman Chemical
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Abbvie